Group One Trading’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$893K Sell
13,200
-9,500
-42% -$538K ﹤0.01% 2832
2025
Q4
$943K Buy
22,700
+100
+0.4% +$4.14K ﹤0.01% 2949
2025
Q3
$910K Buy
22,600
+4,200
+23% +$122K ﹤0.01% 3134
2025
Q2
$478K Buy
18,400
+12,700
+223% +$306K ﹤0.01% 3469
2025
Q1
$140K Sell
5,700
-14,400
-72% -$405K ﹤0.01% 4324
2024
Q4
$576K Buy
+20,100
New +$688K ﹤0.01% 3054

Other funds holding CGON

Group One Trading's CGON Position: Q1 2026 in Review

Group One Trading opened a new position in CG Oncology (CGON) in Q1 2026: 1,435 shares worth $97.1K. The stake represents ﹤0.01% of the portfolio and ranks #4758 among its holdings. This is a return to the name: Group One Trading previously reported a position in CGON as recently as Q2 2025.

Group One Trading first reported a position in CGON in Q2 2025 and has held it in 2 quarters since. The position peaked at $104K in Q2 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Group One Trading held 1,435 shares of CG Oncology worth $97.1K as of Q1 2026.
  • CG Oncology was a new Group One Trading position in Q1 2026.
  • CG Oncology made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4758 holding.
  • Group One Trading first reported a position in CG Oncology in Q2 2025 and has held it in 2 quarters since.
  • Group One Trading's CG Oncology position peaked at $104K in Q2 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.